• US 20180265579A1
  • Filed: 05/24/2018
  • Published: 09/20/2018
  • Est. Priority Date: 12/16/2015
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating fibrosis in a human subject, the method comprising administering to a human subject in need of treatment a therapeutically effective amount of an Interleukin 11 receptor α

  • (IL-11Rα

    ) antibody which is capable of inhibiting Interleukin 11 (IL-11) mediated signalling, wherein the fibrosis is fibrosis of the heart, liver, kidney or eye.

View all claims

    Thank you for your feedback